John Menzies appoints Dr Dermot Smurfit to the Board as the Independent Chairman

– UK, Edinburgh – John Menzies plc (LSE:MNZS), is delighted to announce the appointment of Dr Dermot F Smurfit as Independent Chairman of the Group. His appointment will be effective from the next meeting of the Board on 25 July 2016.

Dr Smurfit brings a wealth of experience to the Board. He is currently Chairman of Powerflute Plc and ML Capital and is a non-executive director of Timber Capital and The Forest Company Limited. He has had an extensive executive career holding a number of positions within the Jefferson Smurfit Group and was latterly Deputy Chairman and World Vice President of Sales and Marketing.

Dermot Jenkinson who had assumed the position of Chairman on an interim basis following the retirement of Iain Napier in May 2016 will continue on the Board as a non-executive director.

Dermot Jenkinson, Chairman of John Menzies plc said: “I am delighted to be able to appoint a Chairman of the calibre of Dr Smurfit. As previously announced I had committed, at short notice, to act as Chairman until such time as a suitable candidate had been found. The obvious qualities that Dr Smurfit possesses and his availability to assume the Chairman responsibilities immediately meant I was happy to recommend his appointment. I am confident that Dr Smurfit will be a great asset to the Group.”

Dr Dermot F Smurfit said: “I am honoured and proud to have been appointed Chairman of John Menzies plc which is an exceptionally strong brand highly trusted by its customers and look forward to assisting the Group in achieving significant growth in the coming years.”

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.

here, the original post =>